Medications Updated During February 2020, From Oldest to Newest

Page 1 of 200 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Divalproex Sodium

Divalproex sodium delayed-release tablet is an anti-epileptic drug indicated for: Treatment of manic episodes associated with bipolar disorder (1.1) Monotherapy and adjunctive therapy of…

Lupin Pharmaceuticals, Inc.1 February 2020

Pioglitazole and Metformin Hydrochloride

Pioglitazone and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with…

Macleods Pharmaceuticals Limited1 February 2020

Losartan Potassium and Hydrochlorothiazide

Losartan potassium and hydrochlorothiazide tablet is a combination of losartan, an angiotensin II receptor blocker (ARB) and hydrochlorothiazide, a diuretic indicated for: Treatment of…

Lupin Pharmaceuticals, Inc.1 February 2020

DESLORATADINE

Desloratadine tablets are histamine-1 (H1) receptor antagonist indicated for: Seasonal Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 12 years of age and older. (1…

Lupin Pharmaceuticals, Inc.1 February 2020

RANOLAZINE

Ranolazine extended-release tablets are an antianginal indicated for the treatment of chronic angina. (1) Ranolazine extended-release tablets are indicated for the treatment of chronic…

Lupin Pharmaceuticals, Inc.1 February 2020

Page 1 of 200 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.